FSM Wealth Advisors’s BeOne Medicines Ltd ONC Stock Holding History

FSM Wealth Advisors’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-671	Closed	-$229K	–	336
2025 Q3	$229K	Buy	+671	New	+$204K	0.03%	288

Other funds holding ONC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

FSM Wealth Advisors's ONC Position: Q4 2025 in Review

FSM Wealth Advisors sold out of BeOne Medicines Ltd (ONC) in Q4 2025, closing a stake of 671 shares — an estimated $229K sold.

FSM Wealth Advisors first reported a position in ONC in Q3 2025 and held it in 1 quarter. The position peaked at $229K in Q3 2025. 286 funds tracked by Wall St. Rank hold ONC as of Q4 2025.

FSM Wealth Advisors reported no remaining BeOne Medicines Ltd position as of Q4 2025 after selling out during the quarter.
FSM Wealth Advisors sold 671 BeOne Medicines Ltd shares in Q4 2025, an estimated $229K.
FSM Wealth Advisors first reported a position in BeOne Medicines Ltd in Q3 2025 and held it in 1 quarter.
FSM Wealth Advisors's BeOne Medicines Ltd position peaked at $229K in Q3 2025.
286 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q4 2025.

Based on FSM Wealth Advisors's 13F filing for Q4 2025, filed 23 Jan 2026.